MatsukiyoCocokara & Co
3088.TMEDIUMScore: 37.6Core · Weight: 8%· Data as of 2026-05-28
Investment Thesis
Japan's largest drugstore chain (3,328+ stores). FY2026 results: Revenue ¥1,117.4B (+5.3%), OP ¥84.9B (+3.5%), NI ¥55.7B (+2.0%). FY2027 guidance: ¥1,155B revenue (+3.4%), OP ¥87.5B (+3.0%). 2031 targets: Revenue ¥1.3T, EBITDA margin ≥13%, ROE ≥12%. DOWNGRADE NOTE: Inbound tourism thesis weakening — China visitors down 56.8% April 2026 (5th consecutive monthly decline). JTB forecasts full-year 2026 inbound down 2.8%. Japan tax-free shopping shifting to refund-based system Nov 2026 — removes in-store convenience for tourists. Shiseido Q1 2026 -3% YoY from same China-Japan tension effect. Domestic business remains solid; tourist upside now a risk, not a tailwind.
Risk
1) China inbound tourism collapse: Chinese visitors down 56.8% April 2026 — 5th consecutive monthly decline. China-Japan diplomatic tensions show no near-term resolution. 2) Tax-free shopping system revision Nov 2026: shift to refund-based model removes in-store purchase convenience. May reduce impulse cosmetics buys. 3) JTB full-year forecast: 41.4M total visitors in 2026, down 2.8% from 2025. Inbound headwind may persist into 2027. 4) Shiseido Q1 2026 sales -3% from same China-Japan tensions — signals supply chain of tourist cosmetics demand under pressure. 5) Domestic competition: AINZ&TULPE, Welcia, Tsuruha competing in urban high-traffic zones.
Monitoring Trigger
REVIEW if: China monthly visitors recover to >500,000 or >50% of 2019 level → re-rate back to HIGH. TRIM if: Same-store-sales decline >3% QoQ driven by tourist segment, OR FY2027 earnings miss guidance. HOLD: Domestic drugstore business stable, 2031 targets intact. Valuation reasonable at PE 16.8x.
Key Dates
Key Metrics
Business Segments
| Segment | Revenue | Share | Description |
|---|---|---|---|
| Matsumotokiyoshi Group | Core drugstore operations, flagship brand | ||
| Cocokara Fine Group | Pharmacy and health/beauty retail | ||
| Management Support | Group logistics, procurement, admin |
Supply Chain Evidence
| Evidence | Customer | Product | Detail |
|---|---|---|---|
| confirmed | Korean tourists | Japanese skincare, face masks, cosmetics | Matsumoto Kiyoshi cited in Korean travel blogs as mandatory stop; Japanese cosmetics cheaper than Korean market |
| confirmed | Chinese tourists | Premium cosmetics, vitamins, supplements | Chinese tourists are highest per-capita cosmetics spenders in Japan; Matsukiyo is primary destination |
| probable | Taiwanese tourists | Cosmetics, OTC medicines, health products | Taiwan #2 inbound market; drugstores a standard itinerary stop |
| confirmed | Inbound Tourists (China/Korea/Taiwan/Southeast Asia) | Japanese cosmetics, skincare, OTC medicines | Company FY2026 disclosure: inbound tourism boosted cosmetics sales. 3,328+ stores incl. urban tourist zones. BUT Chinese visitors -56.8% April 2026. |